Back

Notification report


Full notification file


General information

Notification Number
B/DE/17/PEI3212

Member State to which the notification was sent
Germany

Date of acknowledgement from the Member State Competent Authority
06/10/2017

Title of the Project
A Phase III Multicenter Randomized, Sham Controlled, Study to Determine the Safety and Efficacy of Renexus in Macular Telangiectasia type 2

Proposed period of release:
01/03/2018 to 31/12/2018

Name of the Institute(s) or Company(ies)
Neurotech Pharmaceuticals, Inc., ;


3. Is the same GMO release planned elsewhere in the Community?
Yes:
France; United Kingdom;

Has the same GMO been notified elsewhere by the same notifier?
No

GMO characterization

GMO is a:
Other: mammal

Identity of the GMO:
Genetically engineered cell line derived from homo sapiens donor

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
HumanHomoSapiens---

European Commission administrative information

Consent given by the Member State Competent Authority:
Yes
30/04/2018 00:00:00
Remarks: